Not all magnesium supplements do what they promise. Most forms – magnesium oxide, citrate, glycinate – are effective for muscle function, energy metabolism, and general magnesium repletion. But the brain is a different story. The blood-brain barrier, which shields neural tissue from circulating molecules, blocks the entry of most magnesium forms before they can influence cognitive function.
This is the formulation gap that our patented and clinically studied ingredient Magtein® (Magnesium L-Threonate) was developed to solve. It is the only magnesium compound demonstrated to cross the blood-brain barrier, raise brain magnesium levels, and deliver measurable cognitive benefits in peer-reviewed, double-blind clinical trials.
Avlaan is an authorised Magtein supplier India brands and formulators can partner with to access this patented cognitive health ingredient. Here is what your R&D and procurement teams need to know.
Why the Brain Needs Its Own Magnesium Source
Magnesium is involved in over 300 enzymatic reactions in the body. In the brain specifically, it plays a critical role in synaptic plasticity – the ability of neural connections to strengthen or weaken in response to activity, which underpins learning and memory. When brain magnesium levels fall, synaptic density declines. The result: reduced working memory, slower recall, and greater susceptibility to stress and cognitive fatigue.
The challenge is delivery. Blood magnesium levels and brain magnesium levels are regulated independently. Conventional supplementation can restore peripheral magnesium without materially improving brain magnesium. This is why standard magnesium supplements, despite broad health benefits, show limited cognitive effect in clinical research.
Our patented and clinically studied ingredient Magtein® (Magnesium L-Threonate) addresses this through its threonate component. L-threonate is transported into the brain via glucose transporters, carrying magnesium across the blood-brain barrier and into neuronal cells. This mechanism of action is what distinguishes it from every other magnesium compound.
The Clinical Evidence Behind Magtein®
The clinical dossier behind Magtein® is substantive. Three published, double-blind, placebo-controlled studies validate its cognitive efficacy – the gold standard for nutraceutical ingredient claims.
The Landmark 2016 Study
A 12-week randomised, double-blind, placebo-controlled trial published in the Journal of Alzheimer’s Disease assessed Magtein® across four cognitive domains: executive function, working memory, attention, and episodic memory. Participants receiving Magtein® showed statistically significant improvements across all four areas. The study also reported a reduction in ‘brain age’ of approximately nine years based on cognitive performance metrics – a finding that attracted significant attention in both clinical and consumer wellness circles.
Cognitive Benefits Documented Across Studies
- Working memory and recall: Improvements observed as early as 6 weeks, with continued gains through week 12
- Attention and focus: Reduced cognitive fatigue and improved sustained attention in screen-intensive populations
- Sleep quality: Magtein® supports melatonin regulation, with studies reporting improved sleep onset and duration
- Stress and anxiety response: Magnesium’s role in HPA axis regulation, enhanced by direct brain delivery, supports mood stability
Why the Indian Cognitive Health Market Needs Magtein®
India’s cognitive health supplement segment is being driven by structural demographic and lifestyle shifts that make patented, clinically validated ingredients increasingly valuable for brand differentiation.
The Digital Fatigue Reality
India has among the highest average daily screen times globally, with Gen Z and millennial populations spending 6 to 8 hours daily across professional and social media platforms. The neurological consequences – brain fog, reduced working memory, attention fragmentation, disrupted sleep – are documented in occupational health research. Supplement brands addressing digital fatigue need an ingredient that works at the brain level, not peripherally.
The Ageing Population Opportunity
India’s demographic pyramid is shifting. The 50+ population is growing rapidly, and cognitive health – protecting memory, preventing decline, and maintaining mental clarity – is a primary wellness concern for this cohort. Our patented and clinically studied ingredient Magtein® (Magnesium L-Threonate) has clinical evidence specifically in age-related cognitive support, making it a differentiated choice for active ageing formulations.
Market Validation
Globally, Magtein® has accumulated over 90,000 five-star consumer reviews on Amazon – a real-world validation metric that translates into brand owner confidence. A 17% consumer brand awareness rate for a B2B ingredient is exceptionally high and supports the marketing investment supplement brands make when they feature it on-pack.
Magtein® Ingredient Specifications at a Glance
| Specification | Detail |
| Full Name | Magtein® (Magnesium L-Threonate) |
| Classification | Patented, clinically studied cognitive health ingredient |
| Mechanism | Crosses blood-brain barrier via glucose transporter pathway |
| Clinical Backing | 3 published double-blind, placebo-controlled studies |
| Regulatory Status | FDA affirmed GRAS status; suitable for nutraceutical formulations |
| Standard Dosage | 2g Magtein® per day (1 capsule morning, 2 capsules pre-sleep) |
| Typical Format | Capsules, powder, functional beverages, gummies |
| Consumer Validation | 90,000+ Amazon five-star reviews |
Formulation Applications in the Indian Market
As an authorised Magtein supplier India formulators work with, Avlaan supports ingredient integration across a range of product formats:
- Cognitive health capsules: Standalone or in nootropic stacks with adaptogens, B vitamins, or plant-based phospholipids
- Sleep and recovery formulations: Combined with magnesium glycinate or ashwagandha for evening-use sleep supplements
- Functional beverages: RTD brain health drinks targeting professionals and students
- Active ageing products: Cognitive maintenance supplements for 45+ demographics
- Stress management formulas: HPA axis support combinations featuring Magtein® alongside adaptogens
Key Takeaways for Supplement Brands and Formulators
- Magtein® (Magnesium L-Threonate) is the only magnesium form clinically demonstrated to cross the blood-brain barrier and raise brain magnesium levels
- Three double-blind, placebo-controlled clinical trials document improvements in working memory, attention, recall, and sleep quality
- 90,000+ consumer Amazon reviews provide real-world market validation that supports on-pack featuring and brand investment
- India’s digital fatigue epidemic, growing ageing population, and rising cognitive health awareness create a strong commercial opportunity for Magtein®-based formulations
- Avlaan is an authorised Magtein supplier in India – our team provides full technical documentation, clinical study access, and formulation guidance
| FAQs: Magtein Supplier India |
| 1. What is Magtein® and how does it support brain health? |
| Magtein® (Magnesium L-Threonate) is a patented, clinically studied magnesium compound that crosses the blood-brain barrier via glucose transporters. Once inside neuronal cells, it raises brain magnesium levels, supporting synaptic density, working memory, attention, recall, and sleep quality. It is the only magnesium form proven to work at the brain level. |
| 2. How is Magtein® different from other magnesium supplements? |
| Standard magnesium supplements (oxide, citrate, glycinate) support general health, muscle function, and energy. They do not effectively cross the blood-brain barrier or raise brain magnesium levels. Magtein® (Magnesium L-Threonate) specifically targets brain delivery, making it the preferred choice for cognitive health formulations. |
| 3. What clinical studies support Magtein® efficacy? |
| Three double-blind, placebo-controlled studies support Magtein®’s cognitive efficacy. The landmark 2016 Journal of Alzheimer’s Disease study demonstrated improvements in executive function, working memory, attention, and episodic memory over 12 weeks, with a reported brain age reduction of approximately nine years in study participants. |
| 4. What is the standard dosage for Magtein® in supplement formulations? |
| The clinically studied dose is 2g of Magtein® (Magnesium L-Threonate) per day, typically delivered as one capsule in the morning and two capsules approximately two hours before sleep. This split dosing approach mirrors the protocol used in clinical trials. |
| 5. Is Magtein® suitable for vegan supplement formulations? |
| Yes. Magtein® (Magnesium L-Threonate) is a synthesised mineral compound with no animal-derived components. It is suitable for vegan, vegetarian, and clean-label supplement formulations across categories from cognitive health to sleep and stress management. |
Source Magtein® for Your Cognitive Health Formulation
Avlaan is an authorised supplier of our patented and clinically studied ingredient Magtein® (Magnesium L-Threonate) for nutraceutical brands and formulators in India. We provide full technical documentation, clinical study access, regulatory guidance, and formulation support.
Contact our team: info@avlaanpharma.com | +91 9677 239 111 | Website: avlaanpharma.com
For more details visit FSSAI